Metyletylpyrydynol | Emoxipine injection 10 mg / ml 1 ml ampoules 10 pcs.

Latin name

EMOXIPIN

Release form

Emoxipine. Injection.

Packing

10 ampoules of 1 ml.

Pharmacological action

Angioprotector, reduces the permeability of the vascular wall, is an inhibitor of free radical processes, antihypoxant and antioxidant.

Reduces blood viscosity and platelet aggregation, increases the content of cyclic nucleotides (cAMP and cGMP) in platelets and brain tissue, has fibrinolytic activity, reduces the permeability of the vascular wall and the risk of hemorrhage, promotes their resorption. Expands coronary vessels, in the acute period of myocardial infarction limits the size of the focus of necrosis, improves the contractility of the heart and the function of its conducting system. With increased blood pressure has a hypotensive effect. In acute ischemic disorders of cerebral circulation reduces the severity of neurological symptoms, increases tissue resistance to hypoxia and ischemia.

It has retinoprotective properties, protects the retina from the damaging effects of high-intensity light, promotes resorption of intraocular hemorrhages, improves eye microcirculation.

Indications

Subconjunctival and intraocular hemorrhage, angioretinopathy (including diabetic), chorioretinal dystrophy (including atherosclerotic origin), dystrophic keratitis, retinal vascular thrombosis, complications of myopia, protection of the cornea (when wearing contact lenses) and the retina from exposure to high-intensity light (laser and sunburn, laser-coagulation), trauma, inflammation and burns of the cornea, cataracts (including prevention in people over 40), surgical interventions in the eyes, the condition after surgery for glaucoma with detachment of the choroid.

Contraindications

Hypersensitivity, pregnancy.

Use during pregnancy and lactation

Contraindicated in pregnancy.

Composition

1 ml of solution contains

Active ingredient: methylethylpyridinol hydrochloride (emoxypine) 10 mg

Dosage and administration

Subconjunctival or parabulbar, 1 time per day or every other day. Subconjunctival - 0.2-0.5 ml of 1% solution (2-5 mg), parabulbar - 0.5-1 ml of 1% solution (5-1 mg). The duration of treatment is 10-30 days, a course may be repeated 2-3 times a year.

Side effects

Short-term agitation, drowsiness, increased blood pressure, allergic reactions (skin rashes, etc.), local reactions - pain, burning, itching, hyperemia, densification of paraorbital tissues (resolves independently).

Drug Interaction

Pharmaceutically not compatible with other medicines.

Storage Conditions

In a dark place. Keep out of reach of children.

Shelf life

3 years.

Deystvuyushtee substance

Metilэtilpiridinol

drugstore conditions

drugstore

dosage form

injection

Prescribing

Prescribing

Adults as prescribed by a doctor

Moscow endocrine another factory, Russia